JNJ - J&J's Talvey demonstrates robust long-term response in multiple myeloma
2024-06-14 11:23:25 ET
More on Johnson & Johnson
- Johnson & Johnson: Market Will Regret The Overreaction
- Cancer victims seek court order to block J&J’s bankruptcy bid
- J&J in $700M settlement with states over marketing of talc products
- Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- Johnson & Johnson (JNJ) Bernstein's 40th Annual Strategic Decisions Conference - (Transcript)